Cellebrite DI (CLBT) analyst forecast and price target
Analyst forecast
Consensus of 9 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| DA Davidson | Maintained | Buy | $15.00 | Sep 15, 2026 |
| Needham | Maintained | Buy | $12.50 from $15.00 | Aug 14, 2026 |
| DA Davidson | Maintained | Buy | $15.00 from $22.00 | Aug 14, 2026 |
| JP Morgan | Maintained | Overweight | $16.00 from $20.00 | Aug 14, 2026 |
| Lake Street | Maintained | Buy | $15.00 from $21.00 | Aug 14, 2026 |
| DA Davidson | Maintained | Buy | $22.00 from $20.00 | Aug 6, 2026 |
| DA Davidson | Initiated Coverage | Buy | $20.00 | May 27, 2026 |
| Needham | Maintained | Buy | $15.00 from $18.00 | May 15, 2026 |
| Needham | Maintained | Buy | $18.00 from $24.00 | Feb 12, 2026 |
| Needham | Maintained | Buy | $24.00 from $22.00 | Nov 13, 2025 |
| B of A Securities | Maintained | Buy | $25.00 from $24.00 | Nov 13, 2025 |
| Lake Street | Maintained | Buy | $23.00 from $22.00 | Nov 13, 2025 |
| JP Morgan | Maintained | Overweight | $24.00 from $23.00 | Nov 13, 2025 |
| JP Morgan | Maintained | Overweight | $23.00 from $20.00 | Sep 24, 2025 |
| Lake Street | Maintained | Buy | $22.00 from $24.00 | Aug 15, 2025 |
| Needham | Maintained | Buy | $18.00 from $24.00 | Aug 14, 2025 |
| Needham | Maintained | Buy | $24.00 | Jun 6, 2025 |
| Needham | Maintained | Buy | $24.00 from $28.00 | May 14, 2025 |
| JP Morgan | Maintained | Overweight | $25.00 from $29.00 | May 12, 2025 |
| Needham | Maintained | Buy | $28.00 | Apr 2, 2025 |
Frequently asked questions
What is the price target for CLBT stock?
The average 12-month analyst price target for Cellebrite DI (CLBT) is $14.63, with a high estimate of $16.00 and a low of $12.50, across 4 analysts.
Is CLBT a buy, sell, or hold?
Analysts covering Cellebrite DI currently average a Buy rating: 9 buy, 0 hold and 0 sell, from 9 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CLBT?
The average price target of $14.63 implies 28.51% upside from the last price of $11.38.
What is the latest analyst rating on CLBT?
On Sep 15, 2026, DA Davidson maintained Cellebrite DI at Buy with a price target of $15.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.